RMC-11

N/A

Report date: 2025/01/26 18:02:04
NME

Base Information

Drug NameRMC-11
Drug Alias NamemiR-21 inhibitor (The RNA Medicines Company)RMC-11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Rna Medicines Company Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A